Recent CABA News
- Cabaletta Bio to Participate in Upcoming Investor Conferences in December • GlobeNewswire Inc. • 11/26/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2024 12:05:36 PM
- Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024 • GlobeNewswire Inc. • 11/18/2024 12:00:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/14/2024 06:28:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 12:14:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 12:07:09 PM
- Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/14/2024 12:00:00 PM
- Cabaletta Bio to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference • GlobeNewswire Inc. • 11/06/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2024 10:06:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 08:30:27 PM
- Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024 • GlobeNewswire Inc. • 09/25/2024 08:30:00 PM
- Cabaletta Bio to Participate in Upcoming Investor Conferences in September • GlobeNewswire Inc. • 08/28/2024 12:00:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/22/2024 10:10:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:25:42 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:07:58 AM
- Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/08/2024 11:00:00 AM
- Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum • GlobeNewswire Inc. • 07/02/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 10:06:37 AM
- Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201 • GlobeNewswire Inc. • 06/14/2024 06:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 11:27:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 11:17:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 08:32:55 PM
- Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/29/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 11:53:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 11:04:38 AM
Basanite, Inc. to Open New Production and Distribution Facility in Northeast Ohio • BASA • Jan 2, 2025 8:28 AM
The Crypto Company Highlights Blockchain Training Alliance's Successes and Momentum for 2025 • CRCW • Dec 26, 2024 8:58 AM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM